CHENGDU, China, Jan. 2, 2013 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, has been invited to present at the 6 th Annual OneMedForum San Francisco 2012 on January 9, 2012, at Sir Francis Drake Hotel at 450 Powell Street, San Francisco, CA 94102. Chief Financial Officer of the Company, Dr. James J. Tong is also invited to the 3 rd China Forum panel discussion during the conference.
The OneMedForum San Francisco conference, launched in 2008, runs concurrently with J.P. Morgan conference that provides an efficient access to the companies that shape the future of the rapidly changing healthcare landscape with company presentations, panels and workshops for strategic insights and practical benefits.
OneMed China Forum, focusing on the healthcare market in China, is designed to help senior executives shape strategy to approach what is one of the most lucrative and perilous markets in the world. The program will consist of panel sessions that will address critical issues to understanding how Healthcare and life science companies can succeed in China.Attendees will include institutional investors, senior healthcare executives and life science executives looking for investment opportunities, market insights, licensing opportunities, acquisitions, joint ventures and strategic partnerships. Additional information can be found via: www.onemedplace.com/forum About TPI Headquartered at Chengdu, China, TPI is a pharmaceutical company that specializes in the development, manufacturing, marketing and sales of patented biopharmaceutical, mTCM, branded generics and API. TPI currently manufactures a comprehensive portfolio of 58 products, 24 of which are listed in the highly selective national medicine reimbursement list, 7 are included in the essential drug list of China. For more information about TPI, please visit: http://www.tianyinpharma.com. Safe Harbor Statement
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV